RxDoctor Payments Data

Ursula Corbett, PA

Physician Assistant · Newcomerstown, OHNPI 1407406739

Payments from drug & device makers

$1,067in general payments, 2019–2025

Across 58 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$331
  • AstraZeneca$276
  • Novo Nordisk$137
  • Lilly USA, LLC$110
  • AbbVie$91
  • Boehringer Ingelheim$42
  • plus $80 from 3 others

What the payments were for

  • Food & beverage$1,05699%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,067 in reported general payments places this provider in the 75th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$28,836
Medicare patients
109
Services billed
505

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide162$213,472
FarxigaDapagliflozin Propanediol58$67,976
JardianceEmpagliflozin58$62,891
EliquisApixaban54$56,809
JanuviaSitagliptin Phosphate31$33,697
Breztri AerosphereBudesonide/Glycopyr/Formoterol46$30,832
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$30,525
OzempicSemaglutide30$29,517
XareltoRivaroxaban27$25,306
Breo ElliptaFluticasone/Vilanterol22$11,925
Tresiba Flextouch U-100Insulin Degludec18$10,419
Repatha SyringeEvolocumab14$8,925
TradjentaLinagliptin13$6,706
MotegrityPrucalopride Succinate11$5,735
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$4,916

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Olanzapine$110$214,742186 claims
AstraZenecaFarxiga, Breztri Aerosphere$276$98,808104 claims
Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr$42$73,19983 claims
Novo NordiskOzempic$137$29,51730 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Newcomerstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →